Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instance_of |
gptkb:Company
|
| gptkbp:bfsLayer |
5
|
| gptkbp:bfsParent |
gptkb:Lerer_Hippeau
|
| gptkbp:acquisition |
Type 1 Technologies, Inc.
|
| gptkbp:ceo |
gptkb:John_Sheridan
|
| gptkbp:employees |
approximately 500
|
| gptkbp:focus |
Diabetes management solutions
|
| gptkbp:founded |
gptkb:2006
|
| gptkbp:founder |
gptkb:Kim_Blickenstaff
|
| gptkbp:headquarters |
gptkb:San_Diego,_California
|
| https://www.w3.org/2000/01/rdf-schema#label |
Tandem Diabetes Care, Inc.
|
| gptkbp:industry |
gptkb:hospital
|
| gptkbp:market |
gptkb:Europe
gptkb:Asia gptkb:North_America |
| gptkbp:partnership |
gptkb:Dexcom,_Inc.
gptkb:Abbott_Laboratories gptkb:Insulet_Corporation |
| gptkbp:products |
gptkb:t:slim_Insulin_Pump
gptkb:t:slim_X2_Insulin_Pump gptkb:Control-IQ_Technology |
| gptkbp:regulatory_compliance |
gptkb:FDA
|
| gptkbp:revenue |
$200 million (2020)
|
| gptkbp:stock_exchange |
gptkb:NASDAQ
|
| gptkbp:symbol |
gptkb:TNDM
|
| gptkbp:website |
www.tandemdiabetes.com
|